Trial Profile
6 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast Cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Feb 2011
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Aromatase inhibitors; Cyclophosphamide; Epirubicin; Fluorouracil; Tamoxifen
- Indications Breast cancer
- Focus Therapeutic Use
- 12 Dec 2010 Status changed from active, no longer recruiting to completed.
- 05 Jun 2009 New trial record.